SUR'TOUCH
The SMART SENSORS for Surgery and Medicine
OUR VISION
"At SUR’TOUCH, we are committed to launching on the global market a range of ground breaking surgical and medical devices to improve outcomes ,whilst dramatically reducing costs and allowing clinicians to perform a heightened level of surgery with a greater assurance for patients...
We therefore believe that SUR’TOUCH will set new standards in real time diagnosis and will become an indispensable tool worldwide for cancer, abnormal tissue surgery and critical medical detection. Our products combine a strong physician support and an economic rationale for healthcare systems to purchase."
80 %
of solid tumors require surgery
$6,5 Billion
Global market for image-guided surgery devices
$12,43
return per dollar invested for comprehensive scale up in cancer treatment...
Our Objectives
Real time diagnostic
Our first range of Diagnostic devices are Cancer and Abnormal tissue detectors designed to reduce morbidity and mortality, allowing complete surgical resection of solid tumors and skin cancers with clear margins.
A similar device will be developed for deep Endometriosis surgery.
Because Biological fluid leakage occurs in various situations, SurTouch will introduce a range of sensors for an instantaneous non invasive leakage detection.
In vivo treatment
Using the same core technology, our second range of devices will combine a diagnostic and treatment function "all in one" sensors for multiple indications such as :
Cancer treatment using Electroporation will be possible by using specific focused electrical fields to generate pores in the tumor cells and introduce treatment or, to kill the tumor without causing collateral damage to adjacent tissue.
Wound infection management through a cost effective specific device using electroporation .
Other Products
Additional applications will be developed using our same core patented technology such as "Smart Biopsy" devices and Digital tools for pathology examination or Monitoring devices using RFID technology.
We have considered the needs of Veterinary tumor surgery and SurTouch is therefore developing, through a subsidiary company, a range of devices for the treatment of animals.
Meet our Team
Thierry Desjardins
Founder & CEO
Co-founder of Sur'Touch, Thierry qualified as a Neurosurgeon in 1995 in Nice (France), Thierry's sub specialty in spinal surgery led him to identify the need to detect CSF leakage and develop the concept of a "smart cannula". The same technology has been adopted for abnormal tissue diagnosis in multiple indications after technical discussions with colleagues in different surgical specialties.
Thierry has broadened his surgical skills in the EU, UK, Asia and the Middle East and attended many international conferences.
Nicolas Veau
Founder & CTO
Co-founder of Sur’Touch graduated from Centrale and Supelec engineering schools. Nicolas spent the last 20 years in leadership positions in mobile phone technology and hearing instrument industries as cochlear implant R&D director addressing mechanical, hardware, software and validation domains, and supervising clinical tests. He is recognized for his achievements in diversifying and re-launching new product categories, implementing pioneering R&D initiatives and successfully growing businesses to achieve success on a global scale.
Stephen Long
COO
Stephen has over 30 years experience at executive level in the sales and marketing of medical devices to the healthcare sector. He has worked with a number of multinational blue chip healthcare companies . In 1994 he established Oxford Orthopaedics Ltd (later to become Scient’x UK) selling and marketing the Scient’x range of spinal implants. Within 2 years the company had created a nationwide network of accounts which included some of the most prestigious spinal centres in the UK. From 2005 until 2013 he was General Manager of a UK NHS Medical Centre.